Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Ramasamy, Maheshi N, Minassian, Angela M, Ewer, Katie J, Flaxman, Amy L, Folegatti, Pedro M, Owens, Daniel R, Voysey, Merryn, Aley, Parvinder K, Angus, Brian, Babbage, Gavin, Belij-Rammerstorfer, SandJournal:
The Lancet
DOI:
10.1016/S0140-6736(20)32466-1
Date:
November, 2020
File:
PDF, 1.21 MB
2020
File converter
More search results
More benefits 
